• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Routine Blood Cell Inflammatory Ratios Lack Universal Cutoffs for Clinical Practice

by
November 16, 2026
in Biology
Reading Time: 6 mins read
0
Routine Blood Cell Inflammatory Ratios Lack Universal Cutoffs for Clinical Practice

Routine Blood Cell Inflammatory Ratios Lack Universal Cutoffs for Clinical Practice

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Composite inflammatory indices calculated from routine complete blood count parameters, including the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and systemic immune-inflammation index, have shown extensive statistical correlations with disease severity and mortality across human illnesses, yet they currently lack the robust, externally validated, and transferable cut-off thresholds necessary for routine clinical deployment. In a comprehensive narrative review published in Frontiers in Cell and Developmental Biology, researchers Barbara Ciastek, Katarzyna Kwiatkowska, and Jonas Jurgaitis synthesized international literature identified across PubMed, ScienceDirect, and Google Scholar searches conducted between March 18 and October 19, 2026. The evaluation established that while these ratios represent accessible mathematical combinations of circulating leukocyte and thrombocyte counts, their translation into clinical decision-making is severely constrained by striking threshold variability. Reported clinical thresholds fluctuate dramatically according to disease pathology, clinical stage, selected endpoints, preanalytical sample handling, analytical instrumentation, and statistical derivation techniques. Consequently, existing evidence does not justify the implementation of universal decision cut-offs or the reliance on these mathematical ratios as stand-alone clinical tools.

The biological rationale underlying these four indices rests on the physiological dynamics of circulating leukocyte subsets and thrombocytes, which fluctuate in response to hematopoietic mobilization, tissue recruitment, peripheral consumption, and apoptosis during systemic inflammation. Neutrophils act as primary effector cells of innate immunity that modulate cytokine networks and recruit additional immune populations, while circulating lymphocytes govern antigen-specific adaptive immunity, immunological memory, and inflammatory regulation. Platelets contribute to vascular integrity, release bioactive mediators, and form leukocyte aggregates at the interface of coagulation and inflammation, whereas circulating monocytes migrate into peripheral tissues to differentiate into macrophages and dendritic cells. However, mathematical formulas such as neutrophils divided by lymphocytes, platelets divided by lymphocytes, monocytes divided by lymphocytes, and the product of platelets and neutrophils divided by lymphocytes merely quantify relative cellular abundance rather than functional cellular phenotypes, intracellular signaling pathways, or direct tissue-level inflammatory activity. Crucially, identical ratio values can arise from completely disparate hematological scenarios, such as isolated lymphopenia versus marked granulocytosis, obscuring underlying physiological mechanisms.

Nowhere is this clinical and methodological discordance more pronounced than in cardiovascular medicine, where extensive observational research has linked elevated inflammatory ratios to adverse events while failing to deliver reproducible decision cut-offs. The review highlighted an umbrella review of thirty-five meta-analyses encompassing 106 distinct clinical associations across cardiovascular disorders, which found that despite frequent statistical correlations between elevated neutrophil-to-lymphocyte or systemic immune-inflammation indices and mortality, not a single evaluated association attained high certainty under the Grading of Recommendations Assessment, Development and Evaluation framework, with most rated low or very low certainty. Specific threshold investigations reflect wide divergence: in acute myocarditis across ten international centers, a spline-derived neutrophil-to-lymphocyte ratio of 4.0 or greater predicted all-cause mortality or transplantation with a hazard ratio of 3.25, whereas in non-ST-segment elevation myocardial infarction, a receiver operating characteristic-derived cut-off of 5.509 predicted in-hospital mortality. In critically ill coronary artery disease patients within the MIMIC-IV registry, an inflection threshold of 5.54 emerged alongside a non-linear U-shaped relationship with mortality, while monocyte-to-lymphocyte ratio cut-offs for major adverse cardiac events across nineteen coronary studies ranged from 0.24 to 0.43 without consensus.

Oncological investigations demonstrate similar discrepancies, where proposed prognostic thresholds reflect underlying tumor biology, anatomical site, and therapeutic context rather than universal clinical biological cut-offs. An expansive umbrella review examining 694 associations from 224 published articles on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in malignant disease revealed that only four associations, or approximately 0.6 percent, were supported by convincing evidence. Individual studies underscore how thresholds shift across oncological indications: a baseline neutrophil-to-lymphocyte ratio of 2.5 or greater predicted shorter progression-free survival in hormone receptor-positive, HER2-negative metastatic breast cancer managed with CDK4/6 inhibitors, whereas a cut-off of 3.0 demonstrated prognostic utility specifically in left-sided stage II and III colon cancers following radical resection. In stage IV colorectal cancer, investigators identified distinct thresholds for prognosis, defined by a neutrophil ratio of 6.05 and platelet ratio of 164, versus therapeutic response, which yielded lower thresholds of 5.45 and 155, respectively. Furthermore, in muscle-invasive bladder cancer, platelet-to-lymphocyte ratios independently predicted overall survival while neutrophil-to-lymphocyte ratios lost significance entirely in multivariable modeling, illustrating discordant performance among ratios.

Autoimmune and systemic inflammatory disorders likewise reveal that inflammatory index performance varies according to organ involvement, underlying autoimmune phenotype, and pharmacological exposure. In a prospective UK Biobank cohort evaluation, higher neutrophil-to-lymphocyte ratios correlated with incident autoimmune conditions along a non-linear trajectory with a spline-derived risk threshold around 2.51, although risk magnitudes differed substantially across individual diseases. Within established rheumatoid arthritis, while elevated ratios correlated with general disease activity, specific cut-offs such as an NLR of 3.15 and PLR of 152.62 demonstrated modest discriminatory accuracy for identifying interstitial lung disease complications, yielding area under the curve metrics of 0.615 and 0.610. In Crohn’s disease, investigations into the systemic immune-inflammation index produced disparate optimal cut-offs within the exact same patient cohort: 1092.440 for detecting clinical disease activity, 1907.115 for grading disease severity, and 494.665 for confirming mucosal healing. Concomitant immunosuppressive treatments such as infliximab directly alter circulating ratios, while contradictory findings in Hashimoto’s thyroiditis and Graves’ orbitopathy further illustrate how endocrine and immune heterogeneity complicates cross-study threshold comparisons.

Infectious disease settings present dynamic hematological shifts where the timing of blood draws and clinical contexts decisively dictate optimal numerical thresholds. In geriatric patients with community-acquired bloodstream infections, a high neutrophil-to-lymphocyte cut-off of 8.0 discriminated bacteremia with 72 percent sensitivity and 99 percent specificity, whereas in prospective sepsis cohorts, a much lower threshold of 3.53 was utilized to stratify mortality outcomes, where serial trajectories proved far more informative than isolated baseline measurements. In pediatric community-acquired pneumonia, a discriminatory cut-off of 1.74 was derived to differentiate bacterial from non-bacterial infections, contrasting sharply with intensive care unit evaluations of ventilator-associated pneumonia, where an NLR threshold of 8.26 was identified but provided only modest predictive utility. In septic shock, specialized composite measures such as the neutrophil-to-lymphocyte-to-monocyte ratio yielded a diagnostic cut-off of 43.15 with an area under the curve of 0.88; nevertheless, the review authors cautioned that such findings stem from small single-center retrospective cohorts of 112 patients relying solely on split-sample internal validation.

Chronic metabolic disturbances and nephrological diseases further demonstrate that inflammatory ratios reflect baseline organ dysfunction and hematological shifts rather than singular inflammatory events. A meta-analysis comprising twenty-seven studies and 48,714 individuals confirmed stepwise elevations in neutrophil-to-lymphocyte ratios corresponding to glycemic worsening in type 2 diabetes mellitus, while a thirty-five-study synthesis of 49,664 patients linked higher ratios to diabetic retinopathy, alongside geographic heterogeneity. In chronic hemodialysis cohorts, inflammatory indices have been evaluated across distinct pathophysiological endpoints: platelet-to-lymphocyte cut-offs of 125.5 and neutrophil-to-lymphocyte ratios of 4.4 discriminated erythropoietin resistance, largely driven by profound lymphopenia and perturbed iron metabolism via IL-6 and hepcidin signaling rather than absolute leukocytosis. In vascular access monitoring, pre-operative NLR exceeding 4.21 and PLR exceeding 208.8 correlated with reduced arteriovenous fistula patency, yet only NLR retained independent significance. Meanwhile, in hospitalized end-stage kidney disease patients, 30-day mortality cut-offs jumped to 8.19 for NLR, 0.63 for MLR, and 199.05 for PLR, illustrating that thresholds derived for vascular patency or drug resistance cannot be interchanged with acute survival endpoints.

The synthesis identified five foundational domains of methodological and biological variability that explain why published cut-off values remain inconsistent across the scientific literature. First, population heterogeneity, including baseline demographic variations in age and sex alongside co-existing occult infections, steroid therapies, or myeloid disorders, systematically shifts baseline leukocyte distributions. Second, the spectrum effect across disease stages and clinical endpoints exerts a profound impact; a threshold optimized to detect subclinical disease activity cannot be expected to maintain diagnostic sensitivity when applied to treatment response or long-term mortality. Third, preanalytical sample handling, transport intervals, and laboratory instrumentation introduce non-trivial measurement variability; international surveys from the International Council for Standardization in Haematology highlight persistent differences in internal quality control protocols, target limit calibrations, and analyzer hardware among clinical diagnostic laboratories that propagate directly into calculated mathematical ratios.

Fourth, disparate clinical study designs undermine direct numerical comparisons between published thresholds across medical centers. Investigators frequently apply divergent inclusion criteria, contrast clinical cases against healthy individuals rather than symptomatic disease mimics, or select surrogate imaging markers, such as carotid intima-media thickness, rather than hard clinical cardiovascular events. Fifth, statistical approaches to cut-off derivation generate substantial artificial variance; studies rely variously on arbitrary percentiles, spline inflection points, or data-driven receiver operating characteristic optimizations using the Youden index. Mathematical optimization within single cohorts frequently overfits to sample-specific random noise, generating overoptimistic estimates of sensitivity and specificity that rapidly deteriorate when tested in external populations. Furthermore, mathematical optimization blindly balances false positives and false negatives without weighing the clinical harms of misclassification in real-world patient management.

To overcome these translational hurdles, the review outlines a four-tier research framework to guide future clinical investigations into peripheral blood cell-derived inflammatory indices. Initial efforts must establish rigorous preanalytical and analytical standardization in line with International Council for Standardization in Haematology guidelines while explicitly defining the target population, measurement timing, and specific decision problem prior to data collection. Subsequent research must formally demonstrate that an inflammatory index provides incremental predictive accuracy beyond established laboratory biomarkers, imaging findings, and clinical risk scores rather than merely demonstrating univariable statistical significance. Investigators should also consider preserving ratios as continuous variables within multivariable risk prediction models rather than forcing artificial dichotomization onto non-linear biological phenomena. Ultimately, prospective multicenter cohorts must subject proposed thresholds to rigorous external validation and clinical utility assessments, prioritizing the simplest independently verified markers that genuinely improve patient care over increasingly convoluted mathematical cut-offs.

Subject of Research: Clinical utility and cut-off variability of complete blood count-derived inflammatory indices across human diseases

Article Title: Inflammatory ratios derived from peripheral blood cell counts across human diseases: current evidence and challenges in defining cut-off values

Article References: Ciastek, B., Kwiatkowska, K., & Jurgaitis, J. (2026). Inflammatory ratios derived from peripheral blood cell counts across human diseases: current evidence and challenges in defining cut-off values. Frontiers in Cell and Developmental Biology, 14, 2010268. https://doi.org/10.3389/fcell.2026.2010268

Image Credits: AI Generated

DOI: 10.3389/fcell.2026.2010268

Keywords: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, complete blood count, clinical decision thresholds, cut-off values, systemic inflammation, cardiovascular disease, oncology biomarkers, autoimmune diseases, infectious disease diagnostics, receiver operating characteristic, hemodialysis, biomarker validation, preanalytical variability, spectrum effect

News Source: Drew Townsend. (November 16, 2026). Routine Blood Cell Inflammatory Ratios Lack Universal Cutoffs for Clinical Practice. Scienmag.

Tags: autoimmune diseasesbiomarker validationCardiovascular diseaseclinical decision thresholdscomplete blood countcut-off valueshemodialysisinfectious disease diagnosticsmonocyte-to-lymphocyte ratioNeutrophil-to-lymphocyte ratiooncology biomarkersPlatelet-to-lymphocyte ratiopreanalytical variabilityreceiver operating characteristicspectrum effectsystemic immune-inflammation indexSystemic inflammation
Share12Tweet7Share2ShareShareShare1

Related Posts

Data-Driven Dynamical Models Accurately Predict Social Decision-Making in Trust Games

Data-Driven Dynamical Models Accurately Predict Social Decision-Making in Trust Games

November 18, 2026
Phosphorylated Viral LEF-6 Drives RNA Polymerase Export to Activate Very Late Genes

Phosphorylated Viral LEF-6 Drives RNA Polymerase Export to Activate Very Late Genes

November 18, 2026

LcWRKY18 Represses Anthocyanin Biosynthesis During High Temperature Leaf Fading in Loropetalum

November 18, 2026

Community Mangrove Protection in Belize Could Safeguard Millions in Blue Carbon

November 18, 2026

POPULAR NEWS

  • Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

    Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

    29 shares
    Share 12 Tweet 7
  • Motor Imagery Vividness Shows No Link to Parkinson’s Motor Symptom Severity

    29 shares
    Share 12 Tweet 7
  • Brain Tumour Review Identifies Ferroptosis Checkpoints and Spatial Therapeutic Vulnerabilities

    29 shares
    Share 12 Tweet 7
  • Hepatitis C Vesicles Maintain Immunosuppressive Signals Despite Antiviral Cure in Cirrhosis

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

STING Hyperactivation Suppresses JAK-STAT Signaling in Aging People Living With HIV

Malnutrition Risk Affects Up to 23 Percent of Outpatient Oncology Patients

Apple Ubiquitin Ligase Gene XBMD32 Enhances Drought Tolerance by Reducing Oxidative Stress

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.